Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I safety study of concurrent carbon-ion radiotherapy with cisplatin and S-1 for locally advanced non-small cell lung cancer
jRCTs031190126Phase 1Recruiting
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of cisplatin and tegafur in non-small cell lung cancer (NSCLC). Primary endpoint: Recommended dose of S-1. Started Apr 2020; status: recruiting.
02
Drugs
cisplatintegafur
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCTs031190126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190126.